Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Change in Account Payables came in at -$2.9 million in Q1 2026, down 110.39% year-on-year from $28.3 million in Q1 2025, and down 490.7% quarter-over-quarter from $753000.0 in Q4 2025.
Phibro Animal Health (PAHC) Change in Account Payables (2013 - 2026) Analysis & Trends
Phibro Animal Health's Change in Account Payables history runs 14 years deep, the most recent figure standing at -$2.9 million for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 110.39% year-over-year to -$2.9 million in Q1 2026; TTM through Mar 2026 was -$4.2 million, a 108.96% decrease from a year earlier, with the FY2025 full-year figure at $45.6 million, up 279.62% from the prior year.
- Change in Account Payables fell to -$2.9 million in Q1 2026 per PAHC's latest filing, from $753000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $28.3 million in Q1 2025 and bottomed at -$9.0 million in Q4 2022.
- The 5-year median for Change in Account Payables is $1.3 million (2024), against an average of $2.4 million.
- Biggest YoY gain for Change in Account Payables was 1409.44% in 2022; the steepest drop was 1188.52% in 2022.
- Year by year, Change in Account Payables stood at -$9.0 million in 2022, then jumped by 176.95% to $6.9 million in 2023, then soared by 91.74% to $13.3 million in 2024, then plunged by 94.34% to $753000.0 in 2025, then sank by 490.7% to -$2.9 million in 2026.
- Per Business Quant, the three latest PAHC Change in Account Payables figures stand at -$2.9 million (Q1 2026), $753000.0 (Q4 2025), and -$4.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | -2.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.94 Mn |
| Mar 31, 2026 | -2.94 Mn |
| Dec 31, 2025 | 753,000.00 |
| Dec 31, 2025 | 753,000.00 |
| Sep 30, 2025 | -4.63 Mn |
| Sep 30, 2025 | -4.63 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.62 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Mar 31, 2025 | 28.33 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Jun 30, 2024 | 3.90 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Mar 31, 2024 | -3.44 Mn |
| Dec 31, 2023 | 6.94 Mn |
| Dec 31, 2023 | 6.94 Mn |